GENEVA, May 19 (Xinhua) -- The World Health Organization (WHO) validated on Thursday the CONVIDECIA COVID-19 vaccine developed by Chinese developer CanSino Biologics for emergency use, making it the third Chinese vaccine after Sinopharm and Sinopec having been certified by WHO Emergency Use Listi...
"The addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk," said Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products. "W...
has determined that the vaccine meets WHO standards for protection against COVID-19 and that the benefits of the vaccine far outweigh risks," the WHO statement said.
GENEVA, May 19 (Xinhua) -- The World Health Organization (WHO) validated on Thursday the CONVIDECIA COVID-19 vaccine developed by Chinese developer CanSino Biologics for emergency use, making it the third Chinese vaccine after Sinopharm and Sinovac having been certified by WHO Emergency Use ...
As of March 2021, the proportion of Canadian adults who would not get a coronavirus vaccine if it became available to them was around 12 percent. This statistic shows the percentage of respondents in Canada who would and would not get vaccinated against the coronavirus if a vaccine became avail...
China's COVID-19 vaccine approved for WHO emergency use listing DirectorCoronaapprovedGENEVA,June 1(Xinhua)鈥揟he World Health Organization(WHO),on June 1,validated the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use.At the WHO press conference,...
2024年3月21日,世界卫生组织更新了2023年全球疫苗市场报告。尽管报告内容更多基于2022年的内容,但对于了解当前全球疫苗市场仍有参考价值。分析均剔除了COVID-19疫苗内容,经笔者校对梳理、细节补充和简析后,主要监测结果如下: 后疫情时代疫苗生产仍高度集中
“The Technical Advisory Group for Emergency Use Listing, convened by WHO and made up of regulatory experts from around the world, has determined that the vaccine meets WHO standards for protection against COVID-19 and that the benefits of the vaccine far outweigh risks,“ the WHO statement sa...
measures without interfering unnecessarily with trade andair travelacross national boundaries. WHO also keeps member countries informed of the latest developments incancerresearch, drug development, disease prevention, control of drug addiction,vaccineuse, and health hazards of chemicals and other substances...
The COVID-19 vaccine developed by China's Sinopharm has been approved by the World Health Organization (WHO) for "emergency use." This means its safety, efficacy and quality has been checked and it can be used by the international COVAX vaccine effort. WHO Director-General Tedros...